Detection of Electrodermal Activity in Pain 2

Active, not recruitingNCT06677593

View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this study is to investigate the association between self-reported pain and electrodermal activity and to create an algorithm that detects pain and provides timely alarms for rising pain levels in patients with life-threatening illnesses suffering from persistent pain. The study is exploratory. Hypothesis: Electrodermal activity can distinguish different pain intensity levels in patients with chronic pain and a life-threatening disease. Methodology: Thirty-seven patients with cancer and/or chronic obstructive pulmonary disease (COPD) will be identified through hospital record screening. These patients will wear a monitoring device for a maximum of one week and report their pain intensity throughout the day. Analysis: Discriminant analysis will be used to differentiate between mild, moderate, and severe pain. This study is exploratory, generating hypotheses for subsequent phases of the project.

Study details

Official title: Detection of Electrodermal Activity in Pain (DEEP)
Conditions: Cancer
Chronic Obstructive Pulmonary Disease (COPD
Pain
Sponsor: Copenhagen University Hospital, Hvidovre
Collaborators: Aalborg University Hospital
Start date: 2024-11-15
Primary completion: 2026-12-01
Sex: All
Age range: from 18 Years
Results posted: No results posted in this snapshot
Countries: Denmark
Total sites listed: 1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)

Inclusion Criteria: * Danish * Age over 18 * Persistent or recurrent pain (longer than three months) * Cancer: DC01-DC9 or Pulmonary Diseases:DJ40-DJ47 Exclusion Criteria: * A current diagnosis with psychological/ psychiatric disorders * Impaired cognitive function * Substance abuse * A skin condition on the to-be-tested body parts * PHQ-9 reveals suicidal ideation

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06677593